Your immune system has one job — protecting your body from harm. What if you could use your body’s own immune system to help fight melanoma? Immunotherapy helps your immune system better recognize melanoma cancer cells and fight back more effectively.
For people with advanced melanoma, immunotherapy can help slow or stop cancer from growing. These treatments work in different ways to target cancer cells in the body. They may even help people with advanced melanoma live longer.
This article discusses how different types of immunotherapies for melanoma work, when your doctor may recommend them, and what you can expect in your treatment journey.
Several types of immunotherapies are available for the treatment of advanced melanoma, including immune checkpoint inhibitors, interleukin-2, tumor-infiltrating lymphocyte (TIL) therapy, and oncolytic virus therapy.
Your immune system uses checkpoint proteins as “brakes” to keep your immune system cells from attacking when they’re no longer needed. Cancer cells can use these same “brakes” to hide from the immune system.
Checkpoint inhibitors are medications that block these brakes, making it easier for your immune system to recognize and attack cancer cells. There are several types of immune checkpoint inhibitors used to treat melanoma that has spread to other parts of the body. Each type targets a different checkpoint protein.
Immune checkpoint inhibitors used to treat melanoma include:
Immune checkpoint inhibitors are usually given as an intravenous (IV) infusion. Some forms are injected into the fat under the skin. How often you receive treatment depends on the medication and your treatment plan.
Interleukin-2 (IL-2) is an immune system protein that increases the activity and production of immune cells. A laboratory-made form called aldesleukin (Proleukin) can be used to help boost the immune system against melanoma.
High-dose IL-2, given in a hospital or specialized treatment center, has been used to treat advanced melanoma. However, it can cause serious side effects. Newer immunotherapies are used more often and are generally easier to tolerate.
IL-2 is typically given as an IV infusion. It can also be directly injected into the tumor in certain situations. This is called intralesional therapy.
Tumor-infiltrating lymphocyte (TIL) therapy is a treatment that harnesses certain immune cells called T lymphocytes or T cells. These cells are already in the melanoma tumor, trying to fight the cancer.
Lifileucel (Amtagvi) is a type of TIL therapy for adults with melanoma that can’t be removed with surgery or has spread. It’s used after treatment with a PD-1 inhibitor and, if the melanoma has a BRAF V600 mutation, a BRAF inhibitor. It’s the first TIL therapy to be approved.
The treatment process for TIL therapy has several steps, which include:
“Oncolytic” refers to anything that kills or damages cancer cells. Oncolytic viruses are modified in a laboratory to invade and destroy cancer cells. They also help alert the immune system to fight the cancer cells.
There are two oncolytic viruses used for advanced melanoma:
When oncolytic viruses are used depends on the specific treatment and your melanoma. They’re injected directly into a tumor.
Immunotherapy can be recommended as a treatment option at several different points in your treatment journey. It depends on how far the cancer has spread, whether or not it can be removed completely with surgery, and your overall health.
Immunotherapy is often used to treat stage 3 and stage 4 melanoma. It may also be recommended for earlier stages when there’s a higher risk of the cancer coming back.

Here are some situations in which immunotherapy may be an option:
There may also be details about your tumor cells, such as specific gene mutations, that can help guide your doctor on treatment options. For example, testing for a change in a gene called BRAF can help your doctor choose a targeted therapy that targets this mutation.
Immunotherapy can be given in different ways, depending on the treatment.
Some immunotherapies are only given a limited number of times, such as ipilimumab. Other immunotherapies may be continued for up to a year or longer if they’re working and are well tolerated. TIL therapy is different and only given as a one-time infusion.
Ask your doctor what to expect before your first immunotherapy treatment.
The goal of immunotherapy in advanced melanoma is to slow the growth of the tumor, shrink it, and help you live longer while having a better quality of life. Many people respond very well to immunotherapy, and its effects may last for years.

However, immunotherapy doesn’t work for everyone. Doctors can’t always predict how your body will respond to treatment. Even if you’re feeling better, continue to follow up with your doctor and have the scans they recommend.
The side effects of immunotherapy depend on which treatment you’re on. If you’re taking a combination therapy, such as ipilimumab plus nivolumab, side effects may be more severe.
Read more details about the side effects of immunotherapy.
There are several immunotherapy treatment options for advanced melanoma. The best choice depends on your personal melanoma treatment journey and overall health.
Ask your doctor which treatments may be best for you and why. Asking about the potential benefits, risks, and side effects can help you feel more confident in deciding on a treatment plan.
Tell your doctor about your treatment goals, including what matters to you most. Your preferences and quality of life are important. Together, you and your healthcare team can decide on a treatment plan that fits your needs and goals.
Get updates directly to your inbox.
Become a member to get even more
This is a member-feature!
Sign up for free to view article comments.
We'd love to hear from you! Please share your name and email to post and read comments.
You'll also get the latest articles directly to your inbox.